The Elmezzi Graduate School Of Molecular Medicine
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 4,067 | 904,022 | −899,955 | 0.0 | — |
| 2012 | 4,155 | 985,646 | −981,491 | 0.0 | — |
| 2013 | 3,683 | 1,064,022 | −1,060,339 | 0.0 | — |
| 2014 | 25 | 992,946 | −992,921 | 0.0 | — |
| 2015 | 0 | 906,960 | −906,960 | 0.0 | — |
| 2016 | 0 | 1,164,784 | −1,164,784 | 0.0 | — |
| 2017 | 0 | 1,158,054 | −1,158,054 | 0.0 | — |
| 2018 | 0 | 1,261,373 | −1,261,373 | 0.0 | — |
| 2019 | 0 | 1,094,163 | −1,094,163 | 0.0 | — |
| 2020 | 0 | 1,040,370 | −1,040,370 | 0.0 | — |
| 2021 | 1,705 | 1,204,683 | −1,202,978 | -0.8 | — |
| 2022 | 940 | 1,404,690 | −1,403,750 | -0.8 | — |
| 2023 | 1,354 | 1,056,122 | −1,054,768 | -1.2 | — |
In its most recent public year (2023), this organization spent $1,054,768 more than it brought in. Its liabilities exceeded its net assets — reserves were below zero (-1.2 months), down from 0 in 2011.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
A new entry when its next filing is released. No account, no email; works in any feed reader, Slack, or automation tool. How following works